AzTrials
AzTrials

Early Enteral Feeding AdvancementNCT01337622

Gastric Residuals in Preterm Infants

A study testing No check of gastric residuals for early enteral feeding advancement and Routine check of gastric residuals for early enteral feeding advancement in people with Early Enteral Feeding Advancement and Nutrition, run by McMaster Children's Hospital at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Checking of gastric residuals prior to the continuation/increase of enteral feeding prolongs the time to establish full gastric feeding in the early postnatal period. Read more about this study

Who is it for?
Ages Up to 48 hours
What is being tested?
No check of gastric residuals for early enteral feeding advancement and Routine check of gastric residuals for early enteral feeding advancement
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
87 participants
Where
1 siteCanada
Study dates
Mar 2011to Dec 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 48 hours
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Infants with a birth weight ≥ 1500g and < 2000g
  • Age ≤48 hours of life
  • Informed, written parental consent

Who cannot join

  • Antenatally recognized gastrointestinal malformation
  • Major congenital anomaly
  • Chromosomal anomaly
  • NEC stage II
  • Severe acidosis, asphyxia (pH <7.0)
  • Severe growth restriction below 3rd percentile

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • McMaster Children's Hospital

    Hamilton, Ontario, L8N 3Z5

Other trials in Canada

About this study

Official title: Gastric Residuals in Preterm Infants (GRIP)

Checking of gastric residuals prior to the continuation/increase of enteral feeding prolongs the time to establish full gastric feeding in the early postnatal period.

Being tested
No check of gastric residuals for early enteral feeding advancement, Routine check of gastric residuals for early enteral feeding advancement

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • No check of gastric residuals for early enteral feeding advancementProcedure or surgery

    Discontinuation of gastric feeding and its advancement will be based on clinical examination of the abdomen and gastric aspirates containing blood or significant vomiting.

  • Routine check of gastric residuals for early enteral feeding advancementProcedure or surgery

    Discontinuation of gastric feeding and its advancement will be based on current practice of clinical examination of the abdomen and checking residual before every feed. Volume and color of gastric residual will be considered according to the current guideline.

Study groups in NCT01337622
Study groupRoleWhat they receive
No routine check for gastric residualsExperimentalNot described
Receives: Procedure: No check of gastric residuals for early enteral feeding advancement
Routine check for gastric residualsActive comparatorNot described
Receives: Procedure: Routine check of gastric residuals for early enteral feeding advancement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time to reach full enteral feeding

    Full enteral feeding is defned as an milk intake of equal or more than 120 ml/kg/d.

    Measured: from inclusion (during first 48h of life) until 1 month

Secondary outcomes (1)
  1. growth, tolerance, morbidity

    Time to regain birth weight and maintain weight gain. Incidence of sepsis from birth until 48 hours after parenteral nutrition was administered.

    Use of antibiotics. Incidence of feeding intolerance and necrotizing enterocolitis.

    Measured: from inclusion (during first 48h of life) until one month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Apr 2011 (estimated)
  2. Study startMar 2011
  3. Primary completionDec 2013
  4. Study completionDec 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
87 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01337622
Sponsor's protocol ID
201101GRIP
Status last verified
Mar 2015
First submitted
15 Apr 2011
Last updated
30 Mar 2015
Results posted
No
Data monitoring committee
No

Publications

  • Singh B, Rochow N, Chessell L, Wilson J, Cunningham K, Fusch C, Dutta S, Thomas S. Gastric Residual Volume in Feeding Advancement in Preterm Infants (GRIP Study): A Randomized Trial. J Pediatr. 2018 Sep;200:79-83.e1. doi: 10.1016/j.jpeds.2018.04.072. Epub 2018 Jun 1.

    PubMed 29866595

Questions about this trial

What is this clinical trial studying?

A study testing No check of gastric residuals for early enteral feeding advancement and Routine check of gastric residuals for early enteral feeding advancement in people with Early Enteral Feeding Advancement and Nutrition, run by McMaster Children's Hospital at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Mar 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time to reach full enteral feeding (time frame: from inclusion (during first 48h of life) until 1 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01337622, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Mar 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in